KeyBanc raises Celanese stock price target on turnaround execution
KeyBanc raised its price target on Celanese (NYSE:CE) to $59 from $57, citing strong turnaround execution and improved fundamentals. The firm expects flat EBITDA but increasing EPS due to deleveraging, with free cash flow in the $700M-$800M range. Celanese's Q3 2026 earnings beat estimates, but revenue missed. Citi also raised its target to $65. Analysts highlight attractive valuation metrics.
How this was made
The 30-second read
Why it matters
Analyst upgrades can prompt short-term buying, but the magnitude depends on subsequent earnings and macro conditions.
Market read
Analyst target raises provide a modest catalyst for CE, potentially supporting price gains in the near term.
What to watch
Potential headwinds from Iran-related sanctions and commodity price volatility could limit upside.
Background
The article summarizes recent analyst actions on Celanese, noting both KeyBanc and Citi raising price targets amid a reported turnaround.
Ticker impact
KeyBanc raised its price target on Celanese (CE) to $59 from $57, citing execution of its turnaround and strong free cash flow.
likely upward pressure as investors price in the higher target and improved outlook
The target increase reflects fresh optimism on earnings stability and cash generation, which can attract buying interest.
Market effects
Positive signal for specialty chemicals sector as turnaround execution is highlighted.
Limited to U.S. equities; no broader regional effect.
Minor; primarily affects investors tracking CE and related chemical stocks.
Counterpoint
The target raise may be premature if earnings guidance softens later; investors should watch upcoming guidance.
Key entities
- companyCelanese Corporation
U.S.-listed specialty chemicals producer (ticker CE).
- analyst_firmKeyBanc Capital Markets
Investment bank that raised its price target on CE.
- analyst_firmCiti
Another bank that raised its price target on CE.


